February 22, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered how a protein “master regulator” goes awry, leading to metastasis, the fatal step of cancer.
February 1, 2012
Scientists at the University of California, San Francisco (UCSF) have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease.
January 30, 2012
In the world of bioinformatics, the rush is on to extract gold from a data mine.
January 26, 2012
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
January 23, 2012
After people with low-grade glioma, a type of brain cancer, undergo neurosurgery to remove the tumors, they face variable odds of survival — depending largely on how rapidly the cancer recurs.
January 19, 2012
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, proposed to the University of California Regents on Jan. 19 that a small working group be formed to help UCSF explore options to secure its financial future so it can realize its vision to become the world’s preeminent health sciences innovator.
January 17, 2012
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise.
January 10, 2012
Veterans Affairs hospitals screen elderly men with limited life expectancies for prostate cancer at surprisingly high rates, even though guidelines recommend against such screening, according to a study led by a physician at the UCSF-affiliated San Francisco VA Medical Center (SFVAMC).
January 6, 2012
A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers.
December 23, 2011
A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.